Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...

In the meantime, it’s important for you to be careful around Maurice as the chemo might make you more susceptible to diseases ...

Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

Brukinsa had a lower risk of disease progression or death versus Imbruvica, as well as a more favorable safety profile, in R/R CLL and SLL.

In the meantime, it’s important for you to be careful around Maurice as the chemo might make you more susceptible to diseases ...

Based on the No. 1 podcast of the same name, “Scamanda” tells the story of Amanda Riley, whose tragic cancer tale captivated thousands.

Amanda C. Riley is serving time in prison on fraud-related charges for her fake cancer scam. But where is her husband Cory ...

Fuller House actor Dave Coulier is currently battling stage 3 cancer. Stage 3 cancer is a fairly advanced form of cancer but ...

Bristol Myers on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Breyanzi for the treatment of adults with relapsed or refractory ...